Cargando…
KDM5A Regulates a Translational Program that Controls p53 Protein Expression
The p53 tumor suppressor pathway is frequently inactivated in human cancers. However, there are some cancer types without commonly recognized alterations in p53 signaling. Here we report that histone demethylase KDM5A is involved in the regulation of p53 activity. KDM5A is significantly amplified in...
Autores principales: | Hu, Dongli, Jablonowski, Carolyn, Cheng, Pei-Hsin, AlTahan, Alaa, Li, Chunliang, Wang, Yingdi, Palmer, Lance, Lan, Cuixia, Sun, Bingmei, Abu-Zaid, Ahmed, Fan, Yiping, Brimble, Mark, Gamboa, Nicolas T., Kumbhar, Ramhari C., Yanishevski, David, Miller, Kyle M., Kang, Guolian, Zambetti, Gerard P., Chen, Taosheng, Yan, Qin, Davidoff, Andrew M., Yang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214872/ https://www.ncbi.nlm.nih.gov/pubmed/30388705 http://dx.doi.org/10.1016/j.isci.2018.10.012 |
Ejemplares similares
-
Poly(ADP-ribose) binding and macroH2A mediate recruitment and functions of KDM5A at DNA lesions
por: Kumbhar, Ramhari, et al.
Publicado: (2021) -
Progressive Multifocal Leukoencephalopathy in the Absence of Typical Radiological Changes: Can We Make a Diagnosis?
por: AlTahan, Abdulrahman M., et al.
Publicado: (2019) -
Hypoxia and Hormone-Mediated Pathways Converge at the Histone Demethylase KDM4B in Cancer
por: Yang, Jun, et al.
Publicado: (2018) -
Post COVID-19 Guillain–Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure
por: AlTahan, Abdulrahman M., et al.
Publicado: (2023) -
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma
por: D’Oto, Alexandra, et al.
Publicado: (2021)